General Information of the Compound
Compound ID
CP0689423
Compound Name
US9233111, 3
    Show/Hide
Synonyms
PMID28705083-Compound-28
Pyrrolo[2,3-d]pyrimidine derivative 30
    Show/Hide
Structure
Formula
C31H33FN6O2S
Molecular Weight
572.71
Canonical SMILES
Cc1c(NC(=O)c2cc3c(s2)CCC(C)C3)cc(F)cc1-c1ncnc2[nH]c(C3=CCN(C(=O)N(C)C)CC3)cc12
    Show/Hide
InChI
InChI=1S/C31H33FN6O2S/c1-17-5-6-26-20(11-17)12-27(41-26)30(39)36-24-14-21(32)13-22(18(24)2)28-23-15-25(35-29(23)34-16-33-28)19-7-9-38(10-8-19)31(40)37(3)4/h7,12-17H,5-6,8-11H2,1-4H3,(H,36,39)(H,33,34,35)
    Show/Hide
InChIKey
AFEUSBPUCPEXMI-UHFFFAOYSA-N
Physicochemical Property
logP
6.28172
Rotatable Bonds
4
Heavy Atom Count
41
Polar Areas
94.22
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
41

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 71230726
SID: 163465666
ChEMBL ID
CHEMBL3908775
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01308, Tyrosine-protein kinase BTK
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000040 THP-1 Homo sapiens (Human)  1
1
IC50 = 27 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 5 nM
Clinical Information about the Compound
Drug 1 ( Pyrrolo[2,3-d]pyrimidine derivative 30 )
Drug Name Pyrrolo[2,3-d]pyrimidine derivative 30
Company NOVARTIS AG HENG, Richard HOEGENAUER, Elizabeth, Kate KOCH, Guido PULZ, Robert, Alexander VULPETTI, Anna WAELCHLI, Rudolf
Target(s)
Tyrosine-protein kinase BTK (ATK)
Inhibitor